Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

No Association Between SLC6A4 Gene Polymorphisms With Treatment Remission to Venlafaxine in Han Chinese Depressive Patients.

Clinical neuropharmacology - 1 Jan 2000

Wu Na, Liu Liangjie, Ren Decheng, Yuan Fan, Bi Yan, Guo Zhenming, Hou Binyin, Ji Lei, Han Ke, Feng Mofan, Su Kai, Yu Tao, Li Xingwang, Yang Fengping, Sun Xueli, Dong Zaiquan, Yu Shunying, Yi Zhenghui, Xu Yifeng, He Lin, Wu Shaochang, Zhao Longyou, Changqun Cai, Shi Yi, He Guang

Abstract excerpt

OBJECTIVE: Major depressive disorder (MDD) is a heterogeneous psychiatric disorder and considered to be one of the most common mental diseases worldwide. The antidepressant venlafaxine, as a serotonin noradrenaline reuptake inhibitor, is applied to MDD relief. Solute carrier family 6 member 4 (SLC6A4) has been reported to promote the reuptake of serotonin and to be closely correlated to depression. The present...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to China
Share to Depressive Disorder, Major

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Polymorphism, Single Nucleotide

Share to Selective Serotonin Reuptake Inhibitors

Share to Serotonin Plasma Membrane Transport Proteins

Share to Treatment Outcome

Share to Venlafaxine Hydrochloride

Source

Identifiers

PMID: 33480616
DOI: 10.1097/WNF.0000000000000436

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

No Association Between SLC6A4 Gene Polymorphisms With Treatment Remission to Venlafaxine in Han Chinese Depressive Patients.PMID 33480616Read ↗

SLC6A2 variants may predict remission from major depression after venlafaxine treatment in Han Chinese population.Semantic proximity Read ↗

No association between CYP2C19 genetic polymorphism with treatment remission to antidepressant venlafaxine in Han Chinese population.Semantic proximity Read ↗

A novel NR3C2 polymorphism and the increased thyroid-stimulating hormone concentration are associated with venlafaxine treatment outcome in Chinese Han MDD patients.Semantic proximity Read ↗

Norepinephrine Transporter Gene Variants and Remission From Depression With Venlafaxine Treatment in Older Adults.Semantic proximity Read ↗

<em>5-HTR1A</em> and <em>5-HTR2A </em>genetic polymorphisms and SSRI antidepressant response in depressive Chinese patientsSemantic proximity Read ↗

SLC6A2 and SLC6A4 variants interact with venlafaxine serum concentrations to influence therapy outcome.Semantic proximity Read ↗

Serotonin transporter gene polymorphism associated with short-term treatment response to venlafaxine.Semantic proximity Read ↗

The GG genotype of the serotonin 4 receptor genetic polymorphism, rs1345697, is associated with lower remission rates after antidepressant treatment: Findings from the METADAP cohort.Semantic proximity Read ↗

TPH, SLC6A2, SLC6A3, DRD2 and DRD4 Polymorphisms and Neuroendocrine Factors Predict SSRIs Treatment Outcome in the Chinese Population with Major Depression.Semantic proximity Read ↗

The association between polymorphism of norepinephrine transporter G1287A and major depressive disorder, antidepressant response: a meta-analysis.Semantic proximity Read ↗

[Association of CHRNA4 gene polymorphisms with response to antidepressant among ethnic Han Chinese].Semantic proximity Read ↗

An observational study of Venlafaxine and CYP2D6 in clinical practice.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.